- About
- Advertise
- Author Guidelines
- Contact Us
- Editorial Staff
- Editorial Advisory Board
- Ethics Policy
- Do Not Sell My Personal Information
- Privacy Policy
- Permissions
- Terms and Conditions
© 2021 MJH Life Sciences™ and Chromatography Online. All rights reserved.
Analyzing SARS-CoV-2 Drugs Remdesivir and GS-441524
YMC Europe GmbH
Sponsored Content
A fast separation of remdesivir and its active metabolite GS-441524 for the treatment of COVID-19 is obtained in only 3 minutes using a YMC-Triart C18 UHPLC column.